Abstract
The precise cortical and subcortical mechanisms of Tourette syndrome (TS) are still not fully understood. In the present retrospective analysis, adolescent and adult medication-naïve patients showed increased DA transporter (DAT) binding in nucleus caudate (CAUD), putamen (PUT) and/or whole neostriatum (NSTR). D2 receptor (R) binding and DA release were not different from controls throughout the nigrostriatal and mesolimbocortical system. When patients were medication-free (either medication-naïve or under withdrawal), DAT was still increased in PUT, but not different from controls in CAUD, NSTR and ventral striatum (VSTR). SERT was unaltered in midbrain/pons (MP), but decreased in PUT, thalamus (THAL) and hypothalamus. D2R was unaltered throughout the nigrostriatal and mesolimbocortical system, while DA release was not different from controls in PUT, CAUD and NSTR, but elevated in VSTR. 5-HT2AR binding was unaltered in neocortex and cingulate. In acutely medicated adults, DAT was unaltered in PUT, but still increased in CAUD, whereas DA release remained unaltered throughout the nigrostriatal and mesolimbocortical system. When part of the patients was acutely medicated, vesicular monoamine transporter (VMAT2), DAT, SERT and DA synthesis were not different from controls in striatal regions, whereas D2R was decreased in NSTR, THAL, frontal cortex and limbic regions. Conversely, 5-HT2AR binding was unaltered in striatal regions and THAL, but increased in neocortical and limbic areas. It may be hypothesized that both the DA surplus and the 5-HT shortage in key regions of the nigrostriatal and mesolimbic system are relevant for the bouts of motor activity and the deficiencies in inpulse control.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed., Washington DC, 2013.10.1176/appi.books.9780890425596Search in Google Scholar
Adamczyk, A., Gause, C.D., Sattler, R., Vidensky, S., Rothstein, J.D., Singer, H., and Wang, T. (2011). Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome. Psychiatr. Genet. 21: 90–97. https://doi.org/10.1097/ypg.0b013e328341a307.Search in Google Scholar
Alexander, G.E., DeLong, M.R., and Strick, P.L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9: 357–381. https://doi.org/10.1146/annurev.ne.09.030186.002041.Search in Google Scholar
Bacqué-Cazenave, J., Bharatiya, R., Barrière, G., Delbecque, J.P., Bouguiyoud, N., Di Giovanni, G., Cattaert, D., and De Deurwaerdère, P. (2020). Serotonin in animal cognition and behavior. Int. J. Mol. Sci. 21: 1649.10.3390/ijms21051649Search in Google Scholar
Barr, C.L., Wigg, K.G., Zovko, E., Sandor, P., and Tsui, L.C. (1996). No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am. J. Med. Genet. 67: 301–305. https://doi.org/10.1002/(sici)1096-8628(19960531)67:3<301::aid-ajmg6>3.0.co;2-p.10.1002/(SICI)1096-8628(19960531)67:3<301::AID-AJMG6>3.0.CO;2-PSearch in Google Scholar
Bhikram, T., Elmaghraby, R., Abi-Jaoude, E., and Sandor, P. (2021). An international survey of health care services available to patients with tourette syndrome. Front. Psychiatr. 12: 621874. https://doi.org/10.3389/fpsyt.2021.621874.Search in Google Scholar
Bloch, M.H., Peterson, B.S., Scahill, L., Otka, J., Katsovich, L., Zhang, H., and Leckman, J.F. (2006). Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch. Pediatr. Adolesc. Med. 160: 65–69. https://doi.org/10.1001/archpedi.160.1.65.Search in Google Scholar
Buse, J., Enghardt, S., Kirschbaum, C., Ehrlich, S., and Roessner, V. (2016). Tic frequency decreases during short-term psychosocial stress – an experimental study on children with tic disorders. Front. Psychiatr. 7: 84. https://doi.org/10.3389/fpsyt.2016.00084.Search in Google Scholar
Bortolozzi, A., Díaz-Mataix, L., Scorza, M.C., Celada, P., and Artigas, F. (2005). The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 95: 1597–1607. https://doi.org/10.1111/j.1471-4159.2005.03485.x.Search in Google Scholar
Bouthenet, M.L., Martres, M.P., Sales, N., and Schwartz, J.C. (1987). A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 20: 117–155. https://doi.org/10.1016/0306-4522(87)90008-x.Search in Google Scholar
Butcher, S.P., Liptrot, J., and Aburthnott, G.W. (1991). Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122: 245–248. https://doi.org/10.1016/0304-3940(91)90869-u.Search in Google Scholar PubMed
Cath, D.C., Hedderly, T., Ludolph, A.G., Stern, J.S., Murphy, T., Hartmann, A., Czernecki, V., Robertson, M.M., Martino, D., Munchau, A., et al.. (2011). ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur. Child Adolesc. Psychiatr. 20: 155–171. https://doi.org/10.1007/s00787-011-0164-6.Search in Google Scholar PubMed PubMed Central
Cavallini, M.C., Di Bella, D., Catalano, M., and Bellodi, L. (2000). An association study between 5-HTTLPRpolymorphism, COMT polymorphism, and Tourette’s syndrome. Psychiatr. Res. 97: 93–100. https://doi.org/10.1016/s0165-1781(00)00220-1.Search in Google Scholar PubMed
Chappell, P.B., Leckman, J.F., Scahill, L.D., Hardin, M.T., Anderson, G., and Cohen, D.J. (1993). Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette’s syndrome: a pilot study. Psychiatr. Res. 47: 267–380. https://doi.org/10.1016/0165-1781(93)90084-t.Search in Google Scholar PubMed
Díaz-Anzaldúa, A., Joober, R., Rivière, J.B., Dion, Y., Lespérance, P., Richer, F., Chouinard, S., and Rouleau, G.A. (2004). Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadianfounder population. Mol. Psychiatr. 9: 272–277.10.1038/sj.mp.4001411Search in Google Scholar PubMed
Erdmann, J., Shimron-Abarbanell, D., Cichon, S., Albus, M., Maier, W., Lichtermann, D., Minges, J., Reuner, U., Franzek, E., Ertl, M.A., et al.. (1995). Systematic screening for mutations in the promoter and thecoding region of the 5-HT1A gene. Am. J. Med. Genet. 60: 393–399. https://doi.org/10.1002/ajmg.1320600509.Search in Google Scholar PubMed
Floresco, S.B. (2015). The nucleus accumbens: an interface between cognition, emotion, and action. Annu. Rev. Psychol. 66: 25–52. https://doi.org/10.1146/annurev-psych-010213-115159.Search in Google Scholar PubMed
Gade, R., Muhleman, D., Blake, H., MacMurray, J., Johnson, P., Verde, R., Saucier, G., and Comings, D.E. (1998). Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotype effect in Tourette syndrome and drug abuse. Mol. Psychiatr. 3: 50–60. https://doi.org/10.1038/sj.mp.4000326.Search in Google Scholar PubMed
Gelernter, J., Kennedy, J.L., Grandy, D.K., Zhou, Q.Y., Civelli, O., Pauls, D.L., Pakstis, A., Kurlan, R., Sunahara, R.K., and Niznik, H.B. (1993). Exclusion of close linkage of Tourette’s syndrome to D1 dopamine receptor. Am. J. Psychiatr. 150: 449–453. https://doi.org/10.1176/ajp.150.3.449.Search in Google Scholar PubMed
Geradin, E., Pochon, J.B., Poline, J.B., Tremblay, L., Van de Moortele, P.F., Levy, R., Dubois, B., Le Bihan, D., and Lehericy, S. (2004). Distinct striatal regions support movement selection, preparation and execution. Neuroreport 15: 2327–2331. https://doi.org/10.1097/00001756-200410250-00005.Search in Google Scholar PubMed
Gilles de la Tourette, G. (1885). Étude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie [French]. Arch. Neurol. 9:158–200.Search in Google Scholar
Girault, J.A., Spampinato, U., Glowinski, J., and Besson, M.J. (1986). In vivo release of /3H/ gamma-aminobutyric acid in the rat neostriatum∼II. Opposing effects of Dl and D2 dopamine receptor stimulation dorsal caudate putamen. Neuroscience 19: 1109–1115. https://doi.org/10.1016/0306-4522(86)90127-2.Search in Google Scholar PubMed
Grigoriadis, N., Simeonidou, C., Parashos, S.A., Alban, M., and Guiba-Tziampiri, O. (1996). Ontogenetic development of the locomotor response to levodopa in the rat. Pediatr. Neurol. 14: 41–45. https://doi.org/10.1016/0887-8994(95)00225-1.Search in Google Scholar PubMed
Gobert, A. and Millan, J.M. (1999). Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38: 315–317. https://doi.org/10.1016/s0028-3908(98)00188-9.Search in Google Scholar PubMed
Gonce, M. and Barbeau, A. (1977). Seven cases of Gilles de la tourette’s syndrome: partial relief with clonazepam: a pilot study. Can. J. Neurol. Sci. 4: 279–283. https://doi.org/10.1017/s0317167100025129.Search in Google Scholar PubMed
Grillner, S. and Robertson, B. (2015). The basal ganglia downstream control of brainstem motor centres-an evolutionarily conserved strategy. Curr. Opin. Neurobiol. 33: 47–52. https://doi.org/10.1016/j.conb.2015.01.019.Search in Google Scholar PubMed
Haber, S.N. (2003). The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 26: 317–330. https://doi.org/10.1016/j.jchemneu.2003.10.003.Search in Google Scholar PubMed
Haber, S.N. (2016). Corticostriatal circuitry. Dialogues Clin. Neurosci. 18: 7–21. https://doi.org/10.31887/dcns.2016.18.1/shaber.Search in Google Scholar
Han, D.D. and Gu, H.H. (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6: 6. https://doi.org/10.1186/1471-2210-6-6.Search in Google Scholar PubMed PubMed Central
Harrison, A.A., Everitt, B.J., and Robbins, T.W. (1997). Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav. Brain Res. 89: 135–149.10.1016/S0166-4328(97)00053-3Search in Google Scholar
Hirschtritt, M.E., Dy, M.E., Yang, K.G., and Scharf, J.M. (2016). Child neurology: diagnosis and treatment of tourette syndrome. Neurology 87: e65–67. https://doi.org/10.1212/wnl.0000000000002977.Search in Google Scholar
Hemming, M. and Yellowlees, P.M. (1993). Effective treatment of Tourette’s syndrome with marijuana. J. Psychopharmacol. 7: 389–391. https://doi.org/10.1177/026988119300700411.Search in Google Scholar PubMed
Hoekstra, P.J., Dietrich, A., Edwards, M.J., Elamin, I., and Martino, D. (2013). Environmental factors in Tourette syndrome. Neurosci. Biobehav. Rev. 37: 1040–1049. https://doi.org/10.1016/j.neubiorev.2012.10.010.Search in Google Scholar PubMed
Hornung, J.P. (2003). The human raphe nuclei and the serotonergic system. J. Chem. Neuroanat. 26: 331–243. https://doi.org/10.1016/j.jchemneu.2003.10.002.Search in Google Scholar PubMed
Huang, Y., Liu, X., Li, T., Guo, L., Sun, X., Xiao, X., Ma, X., Wang, Y., and Collier, D.A. (2001). Cases-control association study and transmission disequilibrium test of T102C polymorphism in 5HT2A and Tourette syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18: 11–13.Search in Google Scholar
Ishizu, K., Smith, D.F., Bender, D., Danielsen, E., Hansen, S.B., Wong, D.F., Cumming, P., and Gjedde, A. (2000). Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release. Synapse 38: 87–101. https://doi.org/10.1002/1098-2396(200010)38:1<87::aid-syn10>3.0.co;2-c.10.1002/1098-2396(200010)38:1<87::AID-SYN10>3.0.CO;2-CSearch in Google Scholar
Jacob, S.N. and Nienborg, H. (2018). Monoaminergic neuromodulation of sensory processing. Front. Neural Circ. 12: 51. https://doi.org/10.3389/fncir.2018.00051.Search in Google Scholar
Kawashima, T. (2018). The role of the serotonergic system in motor control. Neurosci. Res. 129: 32–39. https://doi.org/10.1016/j.neures.2017.07.005.Search in Google Scholar
Kim, D.D., Warburton, D.E.R., Wu, N., Barr, A.M., Honer, W.G., and Procyshyn, R.M. (2018). Effects of physical activity on the symptoms of Tourette syndrome: a systematic review. Eur. Psychiatr. 48: 13–19. https://doi.org/10.1016/j.eurpsy.2017.11.002.Search in Google Scholar
Knight, T., Steeves, T., Day, L., Lowerison, M., Jette, N., and Pringsheim, T. (2012). Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr. Neurol. 47: 77–90. https://doi.org/10.1016/j.pediatrneurol.2012.05.002.Search in Google Scholar
Leckman, J.F., Walker, D.E., and Cohen, D.J. (1993). Premonitory urges in Tourette’s syndrome. Am. J. Psychiatr. 150: 98–102. https://doi.org/10.1176/ajp.150.1.98.Search in Google Scholar
Leckman, J.F., Zhang, H.P., Vitale, A., Lahnin, F., Lynch, K., Bondi, C., Kim, Y.S., and Peterson, B.S. (1998). Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102: 14–19. https://doi.org/10.1542/peds.102.1.14.Search in Google Scholar
Leckman, J.F. (2002). Tourette’s syndrome. Lancet 360: 1577–1586. https://doi.org/10.1016/s0140-6736(02)11526-1.Search in Google Scholar PubMed
Lerner, A., Bagic, A., Simmons, J.M., Mari, Z., Bonne, O., Xu, B., Kazuba, D., Herscovitch, P., Carson, R.E., Murphy, D.L., et al.. (2012). Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain 135: 1926–1936. https://doi.org/10.1093/brain/aws104.Search in Google Scholar PubMed PubMed Central
Lucas, G. and Spampinato, U. (2000). Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum J. Neurochem. 74: 693–701. https://doi.org/10.1046/j.1471-4159.2000.740693.x.Search in Google Scholar PubMed
Mahone, E.M., Puts, N.A., Edden, R.A.E., Ryan, M., and Singer, H.S. (2018). GABA and glutamate in children with Tourette syndrome: a 1H MR spectroscopy study at 7T. Psychiatry Res. Neuroimaging 273: 46–53. https://doi.org/10.1016/j.pscychresns.2017.12.005.Search in Google Scholar PubMed PubMed Central
Matsuda, N., Nonaka, M., Kono, T., Fujio, M., Nobuyoshi, M., and Kano, Y. (2020). Premonitory awareness facilitates tic suppression: subscales of the premonitory urge for tics scale and a new self-report questionnaire for tic-associated sensations. Front. Psychiatr. 11: 592. https://doi.org/10.3389/fpsyt.2020.00592.Search in Google Scholar PubMed PubMed Central
Micheli, F., Gatto, M., Lekhuniec, E., Mangone, C., Fernandez Pardal, M., Pikielny, R., and Casas Parera, I. (1990). Treatment of Tourette’s syndrome with calcium antagonists. Clin. Neuropharmacol. 13: 77–83. https://doi.org/10.1097/00002826-199002000-00008.Search in Google Scholar PubMed
Moghaddam, B. and Bunney, B.S. (1990). Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54: 1755–1760. https://doi.org/10.1111/j.1471-4159.1990.tb01230.x.Search in Google Scholar PubMed
Niesler, B., Frank, B., Hebebrand, J., and Rappold, G. (2005). Serotonin receptor genes HTR3A and HTR3B are notinvolved in Gilles de la Tourette syndrome. Psychiatr. Genet. 15: 303–304. https://doi.org/10.1097/00041444-200512000-00015.Search in Google Scholar PubMed
Nikolaus, S., Antke, C., and Müller, H.W. (2009). In vivo imaging of synaptic function in the central nervous system. II. Mental and affective disorders. Behav. Brain Res. 204: 32–66. https://doi.org/10.1016/j.bbr.2009.06.009.Search in Google Scholar PubMed
Nikolaus, S., Beu, M., Antke, C., and Müller, H.W. (2010). Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders – results from in vivo imaging studies. Rev. Neurosci. 21: 119–139. https://doi.org/10.1515/revneuro.2010.21.2.119.Search in Google Scholar PubMed
Nikolaus, S., de Souza Silva, M.A., Hautzel, H., and Müller, H.W. (2013). The neurotachykinin NK1 receptor – a novel target for diagnostics and therapy. Curr. Mol. Imag. 3: 130–147. https://doi.org/10.2174/2211555211302020004.Search in Google Scholar
Nikolaus, S., Mamlins, E., Giesel, F.L., Schmitt, D., and Müller, H.W. (2021). Monoaminergic hypo- or hyperfunction inadolescent and adult attention-deficit hyperactivity disorder? Rev. Neurosci. 33: 347–364. https://doi.org/10.1514/revneuro-2021-0083.Search in Google Scholar
Nordstrom, E.J., Bittner, K.C., McGrath, M.J., Parks3rdC.R., and Burton, F.H. (2015). “Hyperglutamatergic cortico-striato-thalamo-cortical circuit” breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome. Brain Res. 1629: 38–53. https://doi.org/10.1016/j.brainres.2015.09.032.Search in Google Scholar PubMed
Parent, A. and Hazrati, L.N. (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20: 91–127. https://doi.org/10.1016/0165-0173(94)00007-c.Search in Google Scholar PubMed
Pauls, D.L., Fernandez, T.V., Mathews, C.A., State, M.W., and Scharf, J.M. (2014). The inheritance of tourette disorder: a review. J. Obsessive Compuls. Relat. Disord. 3: 380–385. https://doi.org/10.1016/j.jocrd.2014.06.003.Search in Google Scholar PubMed PubMed Central
Pehek, E.A. and Yamamoto, B.K. (1994). Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudateputamen. J. Neurochem. 63: 2118–2124. https://doi.org/10.1046/j.1471-4159.1994.63062118.x.Search in Google Scholar PubMed
Pehek, E.A. (1999). Comparison of effects of haloperidol administration on amphetaminestimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J. Pharmacol. Exp. Therapeut. 289: 14–23.Search in Google Scholar
Perlmutter, J.S., Garvey, M.A., Castellanos, X., Mittleman, B.B., Giedd, J., Rapoport, J.L., and Swedo, S.E. (1998). A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am. J. Psychiatr. 155: 1592–1598. https://doi.org/10.1176/ajp.155.11.1592.Search in Google Scholar PubMed
Qi, Y., Zheng, Y., Li, Z., and Xiong, L. (2017). Progress in genetic studies of tourette’s syndrome. Brain Sci. 7: 134. https://doi.org/10.3390/brainsci7100134.Search in Google Scholar PubMed PubMed Central
Scahill, L., Erenberg, G., BerlinJrC.M., Budman, C., Coffey, B.J., Jankovic, J., Kiessling, L., King, R.A., Kurlan, R., Lang, A., et al.. (2006). Contemporary assessment and pharmacotherapy of tourette syndrome. Tourette syndrome association medical advisory board: practice committee. NeuroRx. 3:192–206. https://doi.org/10.1016/j.nurx.2006.01.009.Search in Google Scholar PubMed PubMed Central
Seideman, M.S. and Seideman, T.A. (2020). A review of the current treatment of tourette syndrome. J. Pediatr. Pharmacol. Therapeut. 25: 401–412. https://doi.org/10.5863/1551-6776-25.5.401.Search in Google Scholar PubMed PubMed Central
Shapiro, A.K., Baron, M., Shapiro, E., and Levitt, M. (1984). Enzyme activity in Tourette’s syndrome. Arch. Neurol. 41: 382–385. https://doi.org/10.1038/309382b0.Search in Google Scholar
Stein, D.J. and Stahl, S. (2000). Serotonin and anxiety: current models. Int. Clin. Psychopharmacol. 15 (Suppl. 2): S1–S6. https://doi.org/10.1097/00004850-200008002-00002.Search in Google Scholar PubMed
Tanner, C.M., Goetz, C.G., Klawans, H.L. (1982). Cholinergic mechanisms in Tourette syndrome. Neurology 32: 1315–1317. https://doi.org/10.1212/wnl.32.11.1315.Search in Google Scholar PubMed
Varrone, A., Dickson, J.C., Tossici-Bolt, L., Sera, T., Asenbaum, S., Booij, J., Kapucu, O.L., Kluge, A., Knudsen, G.M., Koulibaly, P.M., et al.. (2013). European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur. J. Nucl. Med. Mol. Imaging 40: 213–227.10.1007/s00259-012-2276-8Search in Google Scholar PubMed
Wu, Q., Reith, M.E., Walker, Q.D., Kuhn, C.M., Carroll, F.I., and Garris, P.A. (2002). Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J. Neurosci. 22: 6272–6281. https://doi.org/10.1523/jneurosci.22-14-06272.2002.Search in Google Scholar
Yagishita, S. (2020). Transient and sustained effects of dopamine and serotonin signaling in motivation-related behavior. Psychiatr. Clin. Neurosci. 74: 91–98. https://doi.org/10.1111/pcn.12942.Search in Google Scholar PubMed
Yan, Q., Reith, M.E., and Yan, S. (2000). Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine. Brain Res. 863: 254–258. https://doi.org/10.1016/s0006-8993(00)02080-1.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
